Does DALFAMPRIDINE Cause Product dose omission issue? 443 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 443 reports of Product dose omission issue have been filed in association with DALFAMPRIDINE (Dalfampridine). This represents 0.8% of all adverse event reports for DALFAMPRIDINE.
443
Reports of Product dose omission issue with DALFAMPRIDINE
0.8%
of all DALFAMPRIDINE reports
4
Deaths
75
Hospitalizations
How Dangerous Is Product dose omission issue From DALFAMPRIDINE?
Of the 443 reports, 4 (0.9%) resulted in death, 75 (16.9%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DALFAMPRIDINE. However, 443 reports have been filed with the FAERS database.
What Other Side Effects Does DALFAMPRIDINE Cause?
Gait disturbance (8,780)
Drug ineffective (6,794)
Fall (5,554)
Therapy cessation (4,580)
Fatigue (3,778)
Balance disorder (3,753)
Multiple sclerosis relapse (3,322)
Condition aggravated (3,240)
Dizziness (2,959)
Urinary tract infection (2,757)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which DALFAMPRIDINE Alternatives Have Lower Product dose omission issue Risk?
DALFAMPRIDINE vs DALTEPARIN
DALFAMPRIDINE vs DAMOCTOCOG ALFA PEGOL
DALFAMPRIDINE vs DANAPAROID
DALFAMPRIDINE vs DANAZOL
DALFAMPRIDINE vs DANICOPAN